Fairmont Chateau Whistler Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

HIV Vaccines (X7)

joint with the meeting on Functional Cures and the Eradication of HIV (X8)

Scientific Organizers: Nicole A. Doria-Rose, Thumbi Ndung'u and Gunilla Karlsson Hedestam


March 24—28, 2019

Fairmont Chateau Whistler, Whistler, British Columbia, Canada


Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation


BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Global Health Travel Award Deadline: Oct 23, 2018 [details]
Scholarship Deadline: Dec 5, 2018 [details]
Discounted Abstract Deadline: Dec 5, 2018 [details]
Abstract Deadline: Dec 18, 2018 [details]
Discounted Registration Deadline: Jan 24, 2019 [details]

Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-X7 "HIV Vaccines" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On December 5, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After December 5, 2018 until December 18, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
December 5, 2018 n/a
Discounted NON-STUDENT Registration
More details
Before and On January 24, 2019 945.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After January 24, 2019 1145.00 USD
Discounted STUDENT Registration
More details
Before and On January 24, 2019 720.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After January 24, 2019 920.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.

Apply for a Scholarship



Discounted Abstract Deadline: December 5, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is December 18, 2018)

Global Health Travel Award Deadline: October 23, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: December 5, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: December 18, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is December 5, 2018)

Discounted Registration Deadline: January 24, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 945.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1145.00 USD*
Student Registration Fee: 920.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, March 24 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 28 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 29 in order to fully experience the meeting.

SUNDAY, MARCH 24

16:00—20:00
Arrival and Registration

Macdonald Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Macdonald Foyer

MONDAY, MARCH 25

07:00—08:00
Breakfast

Frontenac/Empress
08:00—09:30
Welcome and Keynote Session (Joint)
Registered attendees can view abstracts starting on 02/24/2019

Macdonald Ballroom
John R. Mascola, NIAID, National Institutes of Health, USA
Progress in HIV Vaccines

Robert F. Siliciano, Johns Hopkins University School of Medicine, USA
New Insights into the Extent and Dynamics of the Latent Reservoir

Coffee Break

09:50—11:45
Antibodies for Prevention, Treatment and Cure (Joint)
Registered attendees can view abstracts starting on 02/24/2019

Macdonald Ballroom
David D. Ho, Aaron Diamond AIDS Research Center, USA
Engineering Antibodies to Combat HIV/AIDS

Florian Klein, University of Cologne, Germany
Broadly Neutralizing Antibodies for HIV-1 Immunotherapy

Short Talk(s) Chosen from Abstracts

11:45—17:00
On Own for Lunch

11:45—13:00
Poster Setup

Frontenac/Empress
13:00—22:00
Poster Viewing

Frontenac/Empress
14:30—16:30
Workshop 1

Macdonald ABC
Short Talks Chosen from Abstracts

14:30—16:30
Workshop 1

Macdonald DEF
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Macdonald Foyer
17:00—19:00
Clinical Trials for Prevention: Vaccines and Antibodies
Registered attendees can view abstracts starting on 02/24/2019

Macdonald ABC
Glenda Gray, South African Medical Research Council, South Africa
ALVAC-gp120 for Clade C in South Africa

Lawrence Corey, Fred Hutchinson Cancer Research Center, USA
Validating Neutralization as a Mechanistic Surrogate of Protection in Passive Antibody Studies

Beatrice Ondondo, Cardiff Metropolitan University, UK
T-Cell Vaccine Trials

Short Talk(s) Chosen from Abstracts

17:00—19:00
Development of the Innate Cell and Antibody Responses to HIV
Registered attendees can view abstracts starting on 02/24/2019

Macdonald DEF
Galit Alter, Ragon Institute of MGH, MIT and Harvard, USA
Harvesting Innate Immune Cell Function through Vaccination to Control Viral Replication

Michel C. Nussenzweig, HHMI/Rockefeller University, USA
Targeting B Lymphocytes to Control HIV-1

Lynn Morris, National Institute for Communicable Diseases, South Africa
Neutralizing Antibodies, Vaccines and Long-Term Control of HIV Infection

Short Talk(s) Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Frontenac/Empress
19:30—22:00
Poster Session 1

Frontenac/Empress

TUESDAY, MARCH 26

07:00—08:00
Breakfast

Frontenac/Empress
08:00—11:00
New Technologies for Studying and Inducing B Cells
Registered attendees can view abstracts starting on 02/24/2019

Macdonald ABC
Gunilla B. Karlsson Hedestam, Karolinska Institutet, Sweden
Antibody Germline Genes and Impact on Vaccine Responses

Steven E. Bosinger, Emory University, USA
In Vivo Lineage Tracing of Antigen-Specific B Cells After Vaccination

Coffee Break

Adrian B. McDermott, National Institutes of Health, USA
Characterization of Antigen Specific Memory B Cells Following Vaccination

Colin Havenar-Daughton, La Jolla Institute for Immunology, USA
When Designing Vaccines, Consider the Starting Material: The Human B Cell Repertoire

Short Talk(s) Chosen from Abstracts

08:00—11:00
Mechanisms of Viral Expression and Control of Host Cell Function
Registered attendees can view abstracts starting on 02/24/2019

Macdonald DEF
Saba Valadkhan, Case Western Reserve University, USA
Long Non-Coding RNAs Involved in HIV Latency and Reactivation

Eric M. Verdin, Buck Institute For Research On Aging, USA
CRISPR Based Characterizing of Latency-Associated Pathways

Coffee Break

Jonathan Karn, Case Western Reserve University, USA
Signaling Pathways Controlling HIV Reactivation from Latency

Ivan D'Orso, UT Southwestern Medical Center, USA
Transcriptional Regulatory Mechanisms Shaping HIV Proviral Fate

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Frontenac/Empress
13:00—22:00
Poster Viewing

Frontenac/Empress
16:30—17:00
Coffee Available

Macdonald Foyer
17:00—19:00
Antibody-Virus Coevolution: Vaccines and Lessons from Infection
Registered attendees can view abstracts starting on 02/24/2019

Macdonald ABC
Nicole A. Doria-Rose, NIAID, National Institutes of Health, USA
Broadly Neutralizing Antibodies: Lessons from Natural Infection

Mattia Bonsignori, Duke University Medical Center, USA
Multiple Maturation Pathways of the VRC01 Lineage Leading to Neutralization Breadth from the Fully Reverted Unmutated Common Ancestor

Elise Landais, International AIDS Vaccine Initiative, USA
Novel Antibody Lineages

Short Talk(s) Chosen from Abstracts

17:00—19:00
Mechanism and Modulation of Latency
Registered attendees can view abstracts starting on 02/24/2019

Macdonald DEF
Melanie M. Ott, University of California, San Francisco, USA
Transcriptional Control of Viral Latency

Monsef Benkirane, Institut de Genetique Humaine, France
Biomarkers of Latency

Leor S. Weinberger, University of California, San Francisco, USA
Modeling of HIV Latency and Reactivation

Short Talk(s) Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Frontenac/Empress
19:30—22:00
Poster Session 2

Frontenac/Empress

WEDNESDAY, MARCH 27

07:00—08:00
Breakfast

Frontenac/Empress
08:00—11:00
Therapeutic Vaccines and Cure Strategies (Joint)
Registered attendees can view abstracts starting on 02/24/2019

Macdonald Ballroom
Thumbi Ndung'u, University of KwaZulu-Natal, South Africa
Treatment in Acute Infection: Lessons from the FRESH Cohort

Jintanat Ananworanich, US Military HIV Research Program, USA
Therapeutic Vaccines after Early ART: Impact on Viral Load Control Post Interruption

Coffee Break

Beatriz Mothe, IrsiCaixa AIDS Research Institute-HIVACAT, Spain
Therapeutic Vaccines after Early ART: Impact on Reservoir

Warner Craig Greene, Gladstone Institute of Virology and Immunology, USA
Reversing HIV Latency by Activating AKT/mTOR Signaling

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Frontenac/Empress
13:00—22:00
Poster Viewing

Frontenac/Empress
16:30—17:00
Coffee Available

Macdonald Foyer
17:00—19:00
T Cells in HIV Vaccination
Registered attendees can view abstracts starting on 02/24/2019

Macdonald ABC
Christian Brander, Institut de Recerca de la Sida, IrsiCaixa, Spain
Vaccine-Elicited T Cells in Clinical Trials

Jonah B. Sacha, Oregon Health & Science University, USA
Unconventional T Cells: Potential for Induction by Vaccination

David B. Masopust, University of Minnesota, USA
Tissue Resident T Cells

Short Talk(s) Chosen from Abstracts

17:00—19:00
Experimental Molecular Approaches to Targeting Viral Reservoirs
Registered attendees can view abstracts starting on 02/24/2019

Macdonald DEF
Romas Geleziunas, Gilead Sciences, Inc., USA
Attacking Latent Reservoirs

Priti Kumar, Yale School of Medicine, USA
In vivo Gene Therapy and Nano-medicine to Treat HIV

Susana T. Valente, Scripps Florida, USA
Silencing the HIV-1 Reservoir

Short Talk(s) Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Frontenac/Empress
19:30—22:00
Poster Session 3

Frontenac/Empress

THURSDAY, MARCH 28

07:00—08:00
Breakfast

Frontenac/Empress
08:00—11:00
Env Immunogen Design and Evaluation
Registered attendees can view abstracts starting on 02/24/2019

Macdonald ABC
Richard T. Wyatt, IAVI Neutralizing Antibody Center at The Scripps Research Institute, USA
Modified HIV Trimers to Elicit Cross-Neutralizing Responses

Tongqing Zhou, NIAID, National Institutes of Health, USA
Opening and Closing Targets for Broadly Neutralizing Antibodies

Coffee Break

Karin Loré, Karolinska Institutet, Sweden
In vivo Fate of Env and Early Responses upon Immunization

Derek T. O'Hagan, GSK Vaccines, USA
Designing and Building the Next Generation of Vaccine Adjuvants

Short Talk(s) Chosen from Abstracts

08:00—11:00
Targeting and Eradication of HIV
Registered attendees can view abstracts starting on 02/24/2019

Macdonald DEF
David M. Margolis, University of North Carolina at Chapel Hill, USA
Chemotherapuetic Control of Latency

Sharon R. Lewin, University of Melbourne, Australia
New Approaches to Eradicating HIV: Transitioning Experimental Therapeutics into Clinical Trials

Coffee Break

Deborah Persaud, Johns Hopkins Hospital, USA
Latency and Viral Infection in Pediatrics

Lucy Dorrell, University of Oxford, UK
Novel Engineered Immune-Mobilizing T Cell Receptors-Based Drugs (‘ImmTAVs’) to Clear HIV Infection

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

14:30—16:30
Workshop 2

Macdonald ABC
Short Talks Chosen from Abstracts

14:30—16:30
Workshop 2

Macdonald DEF
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Macdonald Foyer
17:00—18:45
From the Lab to the Clinic: A Reality Check for Investigators
Registered attendees can view abstracts starting on 02/24/2019

Macdonald ABC
Mark Connors, NIAID, National Institutes of Health, USA
Getting a Product to a Clinical Trial: The View from the Lab Bench

Hanneke Schuitemaker, Janssen Vaccines & Prevention B.V., Netherlands
Getting a Product to a Clinical Trial: The View from Industry

Antu K. Dey, International AIDS Vaccine Initiative, USA
Translation of Multiple Products from Discovery to the Clinic: The View from a Product Development Center at a Non-Profit Organization

Short Talk Chosen from Abstracts

17:00—18:45
Protect and Kill Strategies to a Functional Cure
Registered attendees can view abstracts starting on 02/24/2019

Macdonald DEF
Paula M. Cannon, University of Southern California, Keck School of Medicine, USA
Genome Engineering Strategies to Generate HIV Resistant Cells

Scott G. Kitchen, University of California, Los Angeles AIDS Institute, USA
Engineering Long-Term HIV-Specific Immunity through Chimeric Antigen Receptors and Stem Cells

Kevin V. Morris, Center for Gene Therapy, City of Hope, USA
Cell Targeted Gene Modification and the Generation of HIV Targeted T-Cells

Short Talk Chosen from Abstracts

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/24/2019

Macdonald ABC
18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/24/2019

Macdonald DEF
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Frontenac/Empress
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Frontenac/Empress

FRIDAY, MARCH 29

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsor for generously supporting this meeting:

Bill & Melinda Gates Foundation

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13AI143345-01

Funding for this conference was made possible (in part) by 1R13AI143345-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional support for this conference from:

Pathogens and Immunity

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676